The Effect of Myofascial Release Technique on Sportive Performance, Balance and Injury Risk in Runners

May 20, 2022 updated by: Istanbul Medipol University Hospital

The Effect of Myofascial Release Technique on Sportive Performance, Balance and Injury Risk in Runners.

In order to investigate the effect of myofascial release technique on sportive performance, balance and injury risk in runners, 49 athletes will include in the study. The myofascial application group (n=26)will receive 12 sessions of 6-weekly lower extremity posterior muscle therapy. The control group (n=23) will continue the routine exercise program.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Running is a sport that involves repetitive movement and is particularly vulnerable to injury in the lower extremities. Myofascial release, on the other hand, is a manual method that is effective in increasing blood and oxygen permeability between tissues, renewing the tissue, protecting it from injury and increasing performance. The aim of our study is to investigate the effect of Myofascial application on sportive performance balance and injury risk in runners. The study will carry out on runners with a 3-month running history. Myofascial application group (n=26) and control group (n=23) will divide into two groups as randomized controlled. My Jump 2 App, Y balance test and Functional Movement Analysis (FMS) will use as assessment methods. The myofascial application group will receive 12 sessions of 6 weeks of therapy for the lower extremity posterior group muscles. The control group will continue the routine exercise program.

Study Type

Interventional

Enrollment (Anticipated)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Sarıyer
      • Istanbul, Sarıyer, Turkey, 34460
        • Backtofit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a running history of more than 3 months
  • Be between 18 and 45 years old
  • Being a healthy individual without chronic disease
  • No acute injury affecting the lower extremity
  • Running at least 5 km a week
  • Willingness to participate in the research

Exclusion Criteria:

  • Pregnancy or suspected pregnancy
  • Use of alcohol or active substance
  • Having another ongoing treatment process
  • Having a history of surgery on the lower extremity
  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myofascial therapy group
The myofascial therapy group (n=26) will receive 12 sessions of 6-weekly lower extremity posterior muscle myofascial therapy.
Other: Myofascial therapy
Running is a sport that involves repetitive movement and is particularly vulnerable to injury in the lower extremities. Myofascial release, on the other hand, is a manual method that is effective in increasing blood and oxygen permeability between tissues, renewing the tissue, protecting it from injury and increasing performance. The aim of our study is to investigate the effect of Myofascial therapy on sportive performance balance and injury risk in runners. The study will carry out on runners with a 3-month running history.
Other Names:
  • Cross-hand technique
No Intervention: Control group
The control group (n=23) will not receive lower extremity posterior muscle myofascial therapy. They will continue the routine exercise program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of myofascial release technique on sportive performance
Time Frame: Baseline and 6th week
Vertical jump test (My jump 2 App.) is a valid, reliable, and useful tool for measuring vertical jump in recreationally active adults
Baseline and 6th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of myofascial release technique on balance
Time Frame: Baseline and 6th week
Y balance test is a functional movement screening device commonly used to predict the risks of injury in athletes.
Baseline and 6th week
The effect of myofascial release technique on injury risk
Time Frame: Baseline and 6th week
The Functional Movement Screen (FMS) was designed to identify functional movement deficits and asymmetries that may be predictive of general musculoskeletal conditions and injuries, with an ultimate goal of being able to modify the identified movement deficits through individualized exercise prescription.
Baseline and 6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul Medipol University Hospital

Investigators

  • Study Chair: Seval Kutlutürk Yıkılmaz, PhD, Medipol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

September 1, 2021

Study Completion (Anticipated)

September 1, 2022

Study Registration Dates

First Submitted

May 10, 2022

First Submitted That Met QC Criteria

May 20, 2022

First Posted (Actual)

May 26, 2022

Study Record Updates

Last Update Posted (Actual)

May 26, 2022

Last Update Submitted That Met QC Criteria

May 20, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • E-10840098-772.02-2678

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofascial therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe